Xilio Therapeutics Inc (XLO)
1.050
-0.03
(-2.73%)
USD |
NASDAQ |
Jun 03, 16:00
1.05
0.00 (0.00%)
Pre-Market: 08:52
Xilio Therapeutics Cash and Short Term Investments (Quarterly): 33.98M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 33.98M |
| December 31, 2023 | 44.70M |
| September 30, 2023 | 59.77M |
| June 30, 2023 | 75.38M |
| March 31, 2023 | 93.27M |
| December 31, 2022 | 120.38M |
| September 30, 2022 | 139.14M |
| Date | Value |
|---|---|
| June 30, 2022 | 159.41M |
| March 31, 2022 | 176.96M |
| December 31, 2021 | 198.05M |
| September 30, 2021 | 99.77M |
| June 30, 2021 | 120.30M |
| December 31, 2020 | 19.24M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
19.24M
Minimum
Dec 2020
198.05M
Maximum
Dec 2021
103.10M
Average
99.77M
Median
Sep 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Gilead Sciences Inc | 4.718B |
| FibroGen Inc | 177.60M |
| Avalo Therapeutics Inc | 110.18M |
| IGM Biosciences Inc | 293.77M |
| AEON Biopharma Inc | -- |